Sulfonylurea vs pioglitazone: effects on endothelial function in type 2 diabetic patients

被引：0
|
作者：
Naka, K. [1 ]
Papathanassiou, K. [1 ]
Kazakos, N. [1 ]
Bechlioulis, A. [1 ]
Pappas, K. [1 ]
Makriyiannis, D. [2 ]
Liveris, K. [2 ]
Tsatsoulis, A. [2 ]
Michalis, L. K. [2 ]
机构：
[1] Univ Ioannina, Sch Med, Dept Cardiol, Michaelid Cardiac Ctr, GR-45110 Ioannina, Greece
[2] G Hatzikosta Gen Hosp, Dept Endocrinol, Ioannina, Greece
来源：
EUROPEAN HEART JOURNAL | 2007年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：466 / 466
页数：1
相关论文
共 50 条
  • [31] Pioglitazone improves endothelial function in non-diabetic patients with coronary artery disease
    Staniloae, C.
    Mandadi, V.
    Kurian, D.
    Coppola, J.
    Bernaski, E.
    El-Khally, Z.
    Morlote, M.
    Pinassi, E.
    Ambrose, J.
    CARDIOLOGY, 2007, 108 (03) : 164 - 169
  • [32] Effects of losartan on urinary albumin excretion and endothelial vasomotor function in type 2 diabetic patients with microalbuminuria
    Tan, KCB
    Chow, WS
    Ai, VHG
    Lam, KSL
    DIABETOLOGIA, 2001, 44 : A276 - A276
  • [33] Sitagliptin vs. pioglitazone as add-on treatments in patients with uncontrolled type 2 diabetes on the maximal dose of metformin plus sulfonylurea
    P. Khaloo
    S. Asadi Komeleh
    H. Alemi
    M. A. Mansournia
    A. Mohammadi
    A. Yadegar
    M. Afarideh
    S. Esteghamati
    M. Nakhjavani
    A. Esteghamati
    Journal of Endocrinological Investigation, 2019, 42 : 851 - 857
  • [34] Sitagliptin vs. pioglitazone as add-on treatments in patients with uncontrolled type 2 diabetes on the maximal dose of metformin plus sulfonylurea
    Khaloo, P.
    Komeleh, S. Asadi
    Alemi, H.
    Mansournia, M. A.
    Mohammadi, A.
    Yadegar, A.
    Afarideh, M.
    Esteghamati, S.
    Nakhjavani, M.
    Esteghamati, A.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2019, 42 (07) : 851 - 857
  • [35] The Effect of Basal Insulin Therapy on Endothelial Function in Type 2 Diabetic Patients
    Makino, Hisashi
    Hishida, Ai
    Koezuka, Ryo
    Tochiya, Mayu
    Ohata, Yoko
    Tamanaha, Tamiko
    Kishimoto, Ichiro
    DIABETES, 2014, 63 : A123 - A123
  • [36] Impact of cardiac magnetic resonance on endothelial function in type 2 diabetic patients
    Xiang, Guangda
    Xiang, Lin
    He, Honglin
    Zhang, Junxia
    Dong, Jing
    ATHEROSCLEROSIS, 2015, 239 (01) : 131 - 136
  • [37] Vascular Endothelial Function Is Not Associated With Albuminuria But With eGFR in Type 2 Diabetic Patients
    Imamura, Satoshi
    Morioka, Tomoaki
    Yamazaki, Yuko
    Kawano, Naoya
    Numaguchi, Ryutaro
    Urata, Hiromi
    Motoyama, Koka
    Mori, Katsuhito
    Fukumoto, Shinya
    Shoji, Tetsuo
    Emoto, Masanori
    Inaba, Masaaki
    DIABETES, 2013, 62 : A114 - A114
  • [38] Effect of Spironolactone on Endothelial and Renal Function in Type 2 Diabetic Patients with Nephropathy
    Bountouvis, Nikolaos
    Skoura, Evangelia
    Moutzouris, Dimitrios-Anestis
    Pastromas, Sokratis
    Siamatras, Thomas
    Politis, Emmanouil
    Rontogianni, Phivi
    Koulouris, Spyridon
    Apostolou, Theofanis
    Ioannidis, Georgios
    DIABETES, 2009, 58 : A212 - A213
  • [39] One-year glycemic control with a sulfonylurea plus pioglitazone versus a sulfonylurea plus metformin in patients with type 2 diabetes
    Hanefeld, M
    Brunetti, P
    Schernthaner, GH
    Matthews, DR
    Charbonnel, BH
    DIABETES CARE, 2004, 27 (01) : 141 - 147
  • [40] Rosiglitazone, but Not Pioglitazone, Improves Myocardial Systolic Function in Type 2 Diabetic Patients: A Tissue Doppler Study
    Pala, Selcuk
    Esen, Oezlem
    Akcakoyun, Mustafa
    Kahveci, Goekhan
    Kargin, Ramazan
    Tigen, Kuersat
    Karaahmet, Tansu
    Acar, Goeksel
    Esen, Ali Metin
    Kirma, Cevat
    ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2010, 27 (05): : 512 - 518
12345